Anuh Pharma Limited Promoter Group Members Seek Reclassification to Public Category Status
Anuh Pharma Limited has received requests from several individuals who are currently classified under the 'Promoter Group' category to be reclassified as public shareholders. This initiative follows multiple requests dated May 19, 2026, from the concerned individuals.The aggregated requests involve promoter group members seeking a status change from the promoter category to the public category based on their shareholdings and involvement with the company.
According to the details provided, the collective holding of the concerned individuals amounts to 9,49,988 equity shares, representing 0.95% of the total shareholding.
A breakdown of the shareholdings requested for reclassification is as follows:
| Name | Number of Equity Shares Held | % of Shareholding |
|---|---|---|
| Kinjal Siddharth Jhaveri | 8,16,160 | 0.81% |
| Nina Vijay Shah | 60,000 | 0.06% |
| Hemant Babubhai Choksi | 24,000 | 0.02% |
| Kiran Piyush Shah | 15,388 | 0.02% |
| Madhurika Narendra Shah | 12,000 | 0.01% |
| Mukesh Kantilal Shah | 14,400 | 0.01% |
| Aruna Navnit Shah | 5,040 | 0.01% |
| Neela Pradeep Shah | 2,800 | 0.003% |
| Vikram Kirtilal Shah | 200 | 0% |
| TOTAL | 9,49,988 | 0.95% |
The company noted that these requests, which come from individuals who claim to no longer be involved in the day-to-day affairs or management, will be considered by the Board of Directors at its ensuing meeting.
The company stated that appropriate steps will be taken to secure necessary shareholder and Stock Exchange approvals, following which the outgoing promoters would be de-promoterized and categorized as public shareholders.
ANUHPHR Stock Price Movement
Shares of Anuh Pharma Limited are currently edging higher to ₹79.95 as of 3:27 PM, rallying 3.08% in live trading. The stock has seen action today, trading within a range of ₹77.79 to ₹79.96 on a volume of 32,505 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.